![]() |
市場調查報告書
商品編碼
1784640
歐洲雷射輔助耳鼻喉手術市場報告(2021-2031 年,範圍、細分、動態和競爭分析)Europe Laser-Assisted ENT Surgery Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis |
歐洲雷射輔助耳鼻喉手術市場規模預計將從 2023 年的 58,880.47 千美元增加到 2031 年的 109,469.65 千美元。預計 2023 年至 2031 年期間該市場的複合年成長率為 8.1%。
執行摘要和歐洲雷射輔助耳鼻喉手術市場分析:
英國政府正在採取措施,推動包括耳鼻喉雷射系統在內的先進技術的整合,以增強醫療服務並改善患者預後。英國國家醫療服務體系 (NHS) 已認知到雷射技術因其精準性和微創性,在各種耳鼻喉科手術中的潛力。這與 NHS 旨在減少等待時間和提高手術治療可及性的更廣泛努力相一致。 Neomed UK 推出了 Nuvolas GREEN ENT 雷射設備,其工作波長為 514 nm,在臨床應用中表現出色,尤其適用於需要高精度和充分止血的手術。該雷射能夠汽化組織,同時對周圍區域的損傷極小,對於希望改善患者預後和縮短康復時間的耳鼻喉科專家來說,它是一個頗具吸引力的選擇。
歐洲雷射輔助耳鼻喉手術市場細分分析:
有助於得出雷射輔助耳鼻喉手術市場分析的關鍵部分是雷射類型、手術類型和最終用戶。
根據雷射類型,雷射輔助耳鼻喉手術市場細分為二氧化碳雷射、Nd.YAG雷射、二極體雷射、藍光雷射、KTP雷射、氬雷射和其他雷射類型。二氧化碳雷射在2023年佔據了最大的市場佔有率。
就手術類型而言,雷射輔助耳鼻喉手術市場分為雷射喉部手術、雷射內視鏡鼻竇手術(較少)、雷射輔助懸雍垂腭咽成形術 (LAUP)、雷射輔助鐙骨切開術、雷射輔助扁桃體切除術和腺樣體切除術、雷射鼻甲縮小術、經口雷射顯微手術 (TLM)、鼻腔手術和其他手術類型。 2023 年,雷射輔助扁桃體切除術和腺樣體切除術佔據了最大的市場佔有率。
根據最終用戶,雷射輔助耳鼻喉手術市場可分為醫院和專科診所、醫生辦公室和其他最終用戶。醫院和專科診所在2023年佔據了最大的市場。
歐洲雷射輔助耳鼻喉手術市場展望
隨著全球醫療保健系統日益重視門診治療,外科手術的格局也不斷演變,雷射輔助手術逐漸成為許多耳鼻喉疾病的首選治療方案。這種轉變受多種因素驅動,包括醫療技術的進步、患者對便利性和縮短復原時間的偏好,以及門診手術的經濟效益。
二氧化碳 (CO2) 雷射和 Nd:YAG 雷射等雷射廣泛應用於各種耳鼻喉手術,包括治療慢性鼻竇炎、扁桃體切除術和腫瘤切除術。這些雷射器能夠精準定位組織,最大限度地減少對周圍區域的損傷,並顯著減少術後併發症。因此,許多曾經需要住院的手術現在可以在門診進行,這與人們對微創技術的日益青睞相一致。
由於門診手術有許多優勢,越來越多的患者選擇門診手術。門診手術通常恢復時間較短,患者能夠更快恢復日常生活。這在快節奏的時代尤其具有吸引力,因為人們往往不願意為了接受手術而長時間休假或中斷個人生活。雷射輔助手術恢復期短、併發症風險低,完美契合了這項需求。患者能夠在當天接受治療並回家,這提升了他們的整體體驗和對醫療保健系統的滿意度。
此外,醫療政策和報銷模式的變化也影響著人們向門診手術的轉變。如今,許多保險公司更青睞門診手術,因為門診手術成本效益高,且病患治療效果良好。報銷策略的這種轉變鼓勵醫療保健機構採用雷射輔助技術,因為它們既能提供高品質的護理,又能滿足保險公司設定的經濟激勵措施。隨著報銷政策的演變,雷射輔助耳鼻喉手術市場有望受益於此類手術的普及和使用率的提高。
因此,對門診手術的需求不斷成長對雷射輔助耳鼻喉手術市場產生了積極影響。
歐洲雷射輔助耳鼻喉手術市場國家洞察
根據地理分類,歐洲雷射輔助耳鼻喉手術市場包括英國、德國、法國、西班牙、義大利和歐洲其他地區。 2023年,德國佔最大佔有率。
在德國,雷射手術正日益成為治療各種耳鼻喉疾病的首選方案。將先進的雷射技術融入耳鼻咽喉科,徹底改變了外科手術的實踐,為患者提供了微創的替代方案,從而加快了康復速度並減少了併發症。 Biolitec 是德國領先的創新雷射系統研發公司之一,專為耳鼻咽喉應用而設計。其 LEONARDO Mini Dual 和 LEONARDO Mini Blue 雷射為頭部頸部的各種手術提供了多功能解決方案。這些雷射利用不同的波長來達到最佳效果,可以精確切除組織並有效治療耳鼻喉疾病,包括腫瘤和慢性鼻竇炎。
歐洲雷射輔助耳鼻喉手術市場公司概況
市場上的一些主要參與者包括 biolitec AG (Biolitec)、Iridex Corporation、Medency、Dimed Laser Technology Co., Ltd.、intros Medical Laser GmbH、ARC Laser GmbH、LightScalpel、GIGAAMEDICAL、INTERmedic ARFRAN、Limmer Laser GmbH、Qolight這些參與者正在採用擴張、產品創新和併購等各種策略,為消費者提供創新產品並增加市場佔有率。
歐洲雷射輔助耳鼻喉手術市場研究方法:
本報告中的資料收集和分析遵循了以下方法:
二手資料研究:研究流程始於全面的二手資料研究,利用內部和外部資源收集每個市場的定性和定量資料。常用的二手資料研究來源包括但不限於:
公司網站、年度報告、財務報表、經紀商分析和投資者介紹。行業期刊及其他相關出版品。政府文件、統計資料庫和市場報告。針對在市場營運的公司的新聞文章、新聞稿和網路廣播。註:公司簡介部分所包含的所有財務資料均已標準化為美元。對於以其他貨幣報告的公司,數據已使用相應年份的相關匯率轉換為美元。
一手研究 Insight Partners 每年都會與行業利益相關者和專家進行大量的一手調查,以驗證其資料分析,並獲得寶貴的見解。這些研究訪談旨在:
驗證並完善二手資料研究的結果。提升分析團隊的專業知識和市場理解。深入了解市場規模、趨勢、成長模式、競爭動態和未來前景。一手資料研究透過電子郵件互動和電話訪談進行,涵蓋不同地區的各種市場、類別、細分市場和次細分市場。參與者通常包括:
產業利害關係人:副總裁、業務發展經理、市場情報經理和國家銷售經理外部專家:估值專家、研究分析師和具有行業專業知識的關鍵意見領袖
The Europe Laser-Assisted ENT Surgery Market size is expected to reach US$ 109,469.65 thousand by 2031 from US$ 58,880.47 thousand in 2023. The market is estimated to record a CAGR of 8.1% from 2023 to 2031.
Executive Summary and Europe Laser-Assisted ENT Surgery Market Analysis:
In the UK, the government is taking initiatives to prompt the integration of advanced technologies, including ENT laser systems, to enhance healthcare delivery and improve patient outcomes. The National Health Service (NHS) has recognized the potential of laser technology in various otolaryngology procedures owing to its precision and minimally invasive nature. This aligns with the NHS' broader efforts to reduce waiting times and improve access to surgical treatments. Neomed UK has launched the Nuvolas GREEN ENT laser device that operates at a wavelength of 514 nm, providing excellent performance in clinical applications, particularly for procedures requiring high precision and adequate hemostasis. The laser's ability to vaporize tissue with minimal damage to surrounding areas makes it an attractive option for ENT specialists looking to improve patient outcomes and reduce recovery times.
Europe Laser-Assisted ENT Surgery Market Segmentation Analysis:
Key segments that contributed to the derivation of the laser-assisted ENT surgery market analysis are laser type, surgery type, and end user.
By laser type, the laser-assisted ENT surgery market is segmented into CO2laser, Nd.YAGlaser, diode laser, blue laser, KTP laser, argon laser, and other laser types. The CO2laser held the largest share of the market in 2023.
In terms of surgery type, the laser-assisted ENT surgery market is divided into laser laryngeal surgery, laser endoscopic sinus surgery (less), laser-assisted uvulopalatoplasty (LAUP), laser-assisted stapedotomy, laser-assisted tonsillectomy and adenoidectomy, laser turbinate reduction, transoral laser microsurgery (TLM), nasal surgery, and other surgery types. The laser-assisted tonsillectomy and adenoidectomy segment held the largest share of the market in 2023.
Based on end-user, the laser-assisted ENT surgery market is categorized into hospitals and specialty clinics, physician office, and other end-users. The hospitals and specialty clinics segment held the largest share of the market in 2023.
Europe Laser-Assisted ENT Surgery Market Outlook
As healthcare systems worldwide increasingly prioritize outpatient care, the landscape of surgical interventions is evolving, with laser-assisted surgeries emerging as a preferred option for many ENT conditions. This shift is driven by several factors, including advancements in medical technology, patient preferences for convenience and reduced recovery times, and the economic benefits of outpatient procedures.
Lasers, such as carbon dioxide (CO2) lasers and Nd: YAG lasers, are widely used in various ENT surgeries, including the treatment of chronic sinusitis, tonsillectomies, and the removal of tumors. These lasers allow for precise tissue targeting, minimizing damage to surrounding areas and significantly reducing postoperative complications. As a result, many procedures that once required hospitalization can now be performed in outpatient settings, aligning with the growing preference for minimally invasive techniques.
Patients are increasingly seeking outpatient procedures due to the numerous advantages they offer. Outpatient surgeries typically involve shorter recovery times, allowing patients to return to their daily activities more quickly. This is particularly appealing in the fast-paced world, where individuals are often reluctant to take extended time off work or disrupt their personal lives for medical procedures. Laser-assisted surgeries, with their reduced recovery periods and lower risk of complications, fit perfectly into this demand. Patients appreciate the ability to undergo treatment and return home the same day, which enhances their overall experience and satisfaction with the healthcare system.
Furthermore, the shift toward outpatient procedures is influenced by changes in healthcare policies and reimbursement models. Many insurance providers now favor outpatient surgeries due to their cost-effectiveness and positive patient outcomes. This shift in reimbursement strategies encourages healthcare providers to adopt laser-assisted techniques, as they can offer high-quality care while meeting the financial incentives set forth by insurers. As reimbursement policies evolve, the laser-assisted ENT surgery market will likely benefit from increased adoption and utilization of these procedures.
As a result, the growing demand for outpatient procedures positively impacts the laser-assisted ENT surgery market.
Europe Laser-Assisted ENT Surgery Market Country Insights
Based on Geography, the Europe laser-assisted ENT surgery market comprises the UK, Germany, France, Spain, Italy, and the Rest of Europe. Germany held the largest share in 2023.
In Germany, laser surgery is becoming increasingly prominent as a preferred treatment option for various conditions affecting the ear, nose, and throat. Integrating advanced laser technologies into otolaryngology has revolutionized surgical practices, offering patients minimally invasive alternatives that result in quicker recovery and reduced complications. Biolitec is one of the prominent companies in Germany that are at the forefront of developing innovative laser systems designed explicitly for ENT applications. Its LEONARDO Mini Dual and LEONARDO Mini Blue lasers provide versatile solutions for a wide range of procedures in the head and neck area. These lasers utilize different wavelengths to achieve optimal results, allowing for precise tissue removal and effective treatment of ENT disorders, including tumors and chronic sinusitis.
Europe Laser-Assisted ENT Surgery Market Company Profiles
Some of the key players operating in the market include biolitec AG (Biolitec); Iridex Corporation; Medency; Dimed Laser Technology Co., Ltd.; intros Medical Laser GmbH; ARC Laser GmbH; LightScalpel; GIGAAMEDICAL; INTERmedic ARFRAN; Limmer Laser GmbH; Qolight Medical Laser; and Sisram Medical Ltd., among others. These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.
Europe Laser-Assisted ENT Surgery Market Research Methodology :
The following methodology has been followed for the collection and analysis of data presented in this report:
Secondary Research The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:
Company websites , annual reports, financial statements, broker analyses, and investor presentations. Industry trade journals and other relevant publications. Government documents , statistical databases, and market reports. News articles , press releases, and webcasts specific to companies operating in the market. Note: All financial data included in the Company Profiles section has been standardized to USD. For companies reporting in other currencies, figures have been converted to USD using the relevant exchange rates for the corresponding year.
Primary Research The Insight Partners' conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis, and gain valuable insights. These research interviews are designed to:
Validate and refine findings from secondary research. Enhance the expertise and market understanding of the analysis team. Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects. Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:
Industry stakeholders : Vice Presidents, business development managers, market intelligence managers, and national sales managers External experts : Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise